Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

By sjmartinez • September 8, 2023

Singh M, Paul MK, Roy S. Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches. Front Oncol. 2023 Aug 23;13:1265523. doi: 10.3389/fonc.2023.1265523. PMID: 37681032; PMCID: PMC10482239.

Tags: breast cancer, drug delivery, HIF-1α, hypoxia, Publications, Pulmonary, Critical Care & Sleep Medicine, tumor microenvironment (TME)

The obstacle is the way: Finding a path to hepatitis C elimination

Lo Re V 3rd, Price JC, Schmitt S, Terrault N, Bhattacharya D, Arohnson A. The obstacle is the way: Finding a path to hepatitis C[...]

Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension

Hoeper MM, Ewert R, Jansa P, Sirenko Y, Skride A, Balagtas C, Hackley S, Vogt S, Abreu P, Haughie S, Hassan T, Oudiz RJ. Randomized,[...]

Evolving growth hormone deficiency: proof of concept

Chimatapu SN, Sethuram S, Samuels JG, Klomhaus A, Mintz C, Savage MO, Rapaport R. Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024[...]